Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Investors Title (ITIC) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for Investors Title (ITIC) over the last 4 years, with Q3 2025 value amounting to $38.2 million.

  • Investors Title's Other Accumulated Expenses rose 312.02% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.2 million, marking a year-over-year increase of 312.02%. This contributed to the annual value of $37.1 million for FY2024, which is 23.42% down from last year.
  • Latest data reveals that Investors Title reported Other Accumulated Expenses of $38.2 million as of Q3 2025, which was up 312.02% from $38.1 million recorded in Q2 2025.
  • In the past 5 years, Investors Title's Other Accumulated Expenses registered a high of $38.2 million during Q3 2025, and its lowest value of $37.0 million during Q1 2025.
  • In the last 4 years, Investors Title's Other Accumulated Expenses had a median value of $37.2 million in 2022 and averaged $37.4 million.
  • In the last 5 years, Investors Title's Other Accumulated Expenses decreased by 23.42% in 2024 and then surged by 312.02% in 2025.
  • Over the past 4 years, Investors Title's Other Accumulated Expenses (Quarter) stood at $37.2 million in 2022, then fell by 0.12% to $37.1 million in 2023, then fell by 0.23% to $37.1 million in 2024, then increased by 3.09% to $38.2 million in 2025.
  • Its Other Accumulated Expenses was $38.2 million in Q3 2025, compared to $38.1 million in Q2 2025 and $37.0 million in Q1 2025.